Lyntris Inc. (NYSE: LYNX) faced selling pressure from its first trade Wednesday, opening $2.00 below...

Lyntris Inc. (NYSE: LYNX) is preparing to raise approximately $492 million in an initial public offe...

The IPO market showed signs of its traditional late-summer slowdown Friday as Latigo Biotherapeutics...

Braveheart Bio, Inc. (NASDAQ: BRVE) delivered one of the strongest biotechnology IPO performances of...

Thousand Oaks, California-based Latigo Biotherapeutics has filed for a Nasdaq IPO seeking to raise a...

San Diego-based BlossomHill Therapeutics has filed for a Nasdaq IPO seeking to raise approximately $...

Attovia Therapeutics (NASDAQ: ATTO) has filed to raise approximately $200 million through an initial...

Braveheart Bio (NASDAQ: BRVE) has filed to raise approximately $300 million through an initial publi...

After a strong stretch for the U.S. IPO market, Thursday's debut of Jersey Mike's (JMKE) and Reforma...